MorphoSys Continues to Build Commercial Presence by Opening new U.S. Headoffice
PLANEGG/MUNICH, GERMANY and BOSTON MA / ACCESSWIRE / November 15, 2019 / MorphoSys (FSE: MOR; Prime Standard Segment; MDAX & TecDAX;...
Day: November 15, 2019
How Technology Trends in Healthcare Will Improve Workflow
Organizational decision-makers continue to make remarkable progress in leveraging technology to improve operations as well as patient treatment outcomes. Long...
CORRECTION: AIM ImmunoTech Provides Business Update for the Third Quarter of 2019
This press release replaces the press release issued 11/15/2019 at 6:30 a.m., which included an incorrect date. The company had...
Humanigen to Present at the 2019 Stifel Healthcare Conference
BURLINGAME, CA / ACCESSWIRE / November 15, 2019 / Humanigen, Inc., (OTCQB:HGEN) ("Humanigen"), a clinical stage biopharmaceutical company focused on...
Applied BioSciences Reports Second Quarter Fiscal Year 2020 Financial Results and Outlines Corporate Strategy
Successfully building BioPharma pipeline in high-value indications Company plans to advance IND-cleared program into a Phase 1 study in a...
Heat Biologics Reports Third Quarter 2019 Results and Provides Corporate Update
Reported Positive Phase 2 Interim Data in Advanced Non-Small Cell Lung Cancer Patients MORRISVILLE, NC / ACCESSWIRE / November 15,...
StageZero Life Sciences Announces Q3 2019 Progress Update
TORONTO, ON / ACCESSWIRE / November 15, 2019 / StageZero Life Sciences, Ltd (TSX:SZLS) (''StageZero'' or the ''Company'') today announced...
AIM ImmunoTech Provides Business Update for the Third Quarter of 2019
OCALA, FL / ACCESSWIRE / November 15, 2019 / AIM ImmunoTech (NYSE American:AIM), an immuno-pharma company focused on the research...
Anika Therapeutics Announces Participation in MEDICA International Trade Fair and International Cartilage Regeneration and Joint Preservation Society Focus Meeting
BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its...
Sphingotec to Present Novel Acute Care Biomarkers and Point-of-Care Diagnostic Solutions at Medica 2019
HENNIGSDORF, GERMANY / ACCESSWIRE / November 15, 2019 / SphingoTec GmbH ("sphingotec") today announced that latest advancements in the development...